Brain Mind, and Pain Patient-centred Innovation Grant
1.1. What is the BMP Grant?
BMP Grant is an initiative of Pain Alliance Europe and Grünenthal Group to identify, stimulate and encourage patient-centric and scientifically robust innovation in the domain of chronic pain and neurological disorders, to stimulate research and access to innovative treatments, to promote prevention and self-management approaches, to decrease stigma, and to work together to improve quality of life for people living with these disabling conditions.
1.2. The Context of the call for proposals
The further aim of the Grant is to create an environment where patient centricity is the basis for future initiatives, to create a sense of innovation with direct impact on patients’ needs, and to create awareness of chronic pain conditions and neurological disorders.
1.3. Financial allocation provided by the BMP Grant
The BMP Grant is allocated to the 3 working streams according to the concrete objectives of the EU Brain, Mind, and Pain Interest Group:
- access to innovative treatments
- prevention and self-management approaches
- reduction of stigma and research into improvements of quality of life
The biennial BMP Grant fund totals 90,000 EUR. This amount will be allocated amongst the 3 BMP Grant working streams according to the decision of the BMP Grant Steering Committee and granted to the winning proposals, following the decision of the BMP Grant Jury for each work stream and edition.
1.4. Indicative timetable
The grant is organised on a biennial basis and the following key dates apply:
|Launch of the Call for Proposal||2nd half of August|
|Start of the Application Period||1 September|
|End of the Application Period||31 December|
|Evaluation period||01 January – 30 April|
|Notification of declination or success of submission||beginning of May
The first edition is programmed for 2017-2018.
RULES OF THE CALL FOR PROPOSALS
Reflecting the first of the BMP Grant work streams “access to innovative treatments” the first edition’s theme is: “Overcoming problems in access to treatments”.
2.2. Specific requirement for eligibility
The submitted project must fulfil the following specific requirements:
- To be patient-driven
- To be patient-centred
- To be scientifically robust
- To respect the theme selected for each grant proposal
- To address the objectives of the Grant
- To be innovative
- To focus on European countries and be conducted in Europe
2.3. Who can apply
Natural persons and /or organisations based and operating in Europe (geographical region) are eligible to apply for the BMP Grant.
2.3.1 Legal identity of the applicants
The BMP Grant applicants must be constituted and functioning within either of the following Legal Identities:
Patient Organisation is a national or regional association with legal identity, which helps patients by providing information about living with their conditions, raising awareness about screening and prevention, and offering a number of supporting tools for improving their life conditions.
The BMP Grant encourages partnerships between different categories of applicants described here above (natural persons, non-profits, educational institutions), believing that a good representation of interests is beneficial to the expected result, which is to improve the life of pain patients.
Independent educational institutions, public and/or state controlled institutions, and private institutions of higher education.
Non-profit organizations, other than institutions of higher education.
Natural Persons may submit applications for a funding opportunity on their own behalf (students, patients, carers, others). However, in order to create the basis for putting into practice the submitted project, we recommend that the respective natural person associates with a patient organisation.
2.3.2. Number of proposals and grants per applicant
Applications will only be accepted via the application procedure online. Applications received before 15 November 2017 will receive advice from the BMP Grant secretariat in case one or several primary eligibility criteria are not met. In this case, a resubmission within the application period will be possible. Correction of the submission or resubmissions can only be made after consultation with the BMP Grant secretariat and within the application period.
2.4. Eligibility of costs
We require that the budget be transparent and sufficiently elaborated in the application and that the periodical reports submitted if the project wins include a detailed financial overview.
Co-funding is accepted, provided the following criteria are met:
- The BMP grant should fuel the project significantly
- The BMP grant has full access to reports and analysis as well as the rights for publication as described in 2.5.3
- The communication takes place according to the terms included in the grant agreement
- The financial data and use of funds are transparent
2.5. How to apply and the procedures to follow
2.5.1. Application form
The application should be submitted online using the Application form available on the website.
The applicant will receive an email confirmation that the application has been submitted.
2.5.2. Application period
The application period starts on 1st September 2017 at 0h00 CET and ends on the 31st December 2017, at 23h59 CET.
2.5.3. Compliance and transparency
Applicants are informed that all submitted applications can be made publicly available to ensure full transparency, for future evaluation, public reporting and promotion of the BMP Grant. By submitting the application, the applicant grants a copyright to BMP Grant and its partners to use the submitted material for publication, promotion and documentation
Furthermore, the BMP Grant organisation and its partners are entitled to publish the grant applications, the motivation of the jury and the amount and conditions of the awarded grants according to national transparency and compliance regulations.
2.6. Evaluation and selection of applications
2.6.1. Evaluation criteria
All applications will be evaluated using the following criteria:
The project should:
- meet the theme of this specific call
- improve the patients’ quality of life
- be innovative
- be targeted at patients with neurological and/or chronic pain disorders
- involve patient organisations in its development
- involve patient organisations in its implementation
- be transferable to other countries and regions
- establish partnerships between stakeholders
- be sustainable and have an impact in the long-term
- have a defined deadline
- have a well-defined implementation plan
2.6.2. Assessment of criteria
The jury will have the final decision on whether or not and if yes, in what extent, an applicant meets the above evaluation criteria. Additionally, the evaluation will:
- assess if the planned outcome of the project will solve a problem for patients
- welcome applications which have considered involving the patients in the realisation of their project
2.6.3. Scientific evaluation
The scientific evaluation will ensure that the project is scientifically robust, and will be
- done separately by two scientific evaluators, who will be free to ask advice from experts in specific fields
- expressed quantitatively by a global scientific score.
188.8.131.52. Notification of the Jury’s decision
The applicants will be notified via email of the Jury’s decisions in the beginning of May.
184.108.40.206. Content of the decision
The BMP Grant Jury will announce the winning project(s) and the allocation of grant funds.
POST FUNDING PROCEDURES
3.1. Reports and Payment Schedule
The BMP Grant Jury can advise on the payment and reporting schedule based on the schedule below for projects deviating from an 18-month schedule. Deviations need to be ratified by the BMP Grant Steering Committee.
|40% of the total amount granted will be paid upon the start of the project|
|Second payment||Based on the Intermediate Project Status Report, 30% of the amount|
|Final payment||At project’s completion, based on the Final Project Report or publication of the results, 30% of the amount|
3.2. Reporting obligations
The payment plan is in accordance with the project’s control and reporting milestones. The candidate will be required to submit an Intermediate Project Status Report, 6 months after the project has started and a Project Evaluation Report 18 months after the date of the first payment.
The candidate will present the results of the project in the circumstances agreed-upon with the BMP Grant Authority in the grant agreement and will contain a video/PPT presentation of the project.
All the above will be detailed in the grant agreement.
The grant winner is responsible for reporting the grant income for tax purposes as required by law.
3.3. Communication plan
The BMP Grant administrative authority wishes to inform its partners of the projects it supports in the field of patient-centred innovation.
The winning project(s) will be advertised via BMP Grant website www.bmp-grant.eu and also in the communication of the BMP Grant authority with its partners, collaborators, and media via email communication, press releases, and other social media channels.
The Project Summary requested within the Application form may be used to publicise your project within the BMP Grant communication plan.
In compliance with the rules of confidentiality and according to the grant agreement, the BMP Grant may propose to the grant winner the organization of joint communications relating to the results of your work.
All the above will be detailed in the grant agreement.
3.4. Publication rules
The winning project will be recognised as a BMP Grant project. Any publication concerning the project will contain the reference to the BMP Grant as defined by the conditions detailed in the grant letter the winner receives.